Original Article
/ VOLUME 6, ISSUE 3, SEPTEMBER 2024
A New Biomarker Copeptin in Determining Disease Severity in COVID-19
Coronavirus disease (COVID-19) remarkably impacted mortality rates and healthcare resources. The causative virus, SARS-CoV-2, is a member of the β family. Pulmonary manifestations of COVID-19 can range from asymptomatic infection to severe pneumonia and acute respiratory distress syndrome. Research regarding risk classifications [...] Read More